Key result
Re-implantation is linked to ~353% higher early TIAP infection risk, while low platelets predict late infection.
Why the study?
What are the complications, causes of removal, and risk factors for infection in pediatric hemato-oncology patients with totally implantable access ports?
Cohort (n=225)
What are the complications, causes of removal, and risk factors for infection in pediatric hemato-oncology patients with totally implantable access ports?
Odds Ratio: 4.528
p-value: p=0.033
In pediatric hemato-oncology patients with TIAPs, re-implantation increases the risk of early infection, while thrombocytopenia is a strong predictor of late infection.
No takes yet. Share an insight, caveat, or question.
Re-implantation and thrombocytopenia were associated with early and late TIAP infections; hypothesis-generating for prevention strategies pending prospective validation.
Nam et al. (2009) conducted a cohort in Pediatric hematology-oncology patients with totally implantable access ports (TIAPs) (n=225). Re-implantation and low platelet count was evaluated on Early infection (OR 4.528, p=0.033). Re-implantation was a significant risk factor for early TIAP infection (OR 4.528, P=0.033), while a platelet count <50,000/mm3 independently predicted late infection (OR 4.24, P=0.005).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: